Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $8.89 USD
Change Today -0.045 / -0.50%
Volume 4.3M
NVAX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

novavax inc (NVAX) Key Developments

Novavax, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

Novavax, Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. Novavax reported a net loss of $24.4 million, or $0.10 per basic and diluted share, for the first quarter of 2015, compared to a net loss of $13.8 million, or $0.07 per basic and diluted share, for the first quarter of 2014. Novavax revenue in the first quarter of 2015 increased 32% to $9.9 million, compared to $7.5 million for the same period in 2014. Net cash used in operating activities for the first quarter of 2015 was $30.5 million, compared to $20.4 million for the same period in 2014. Loss from operations was $24.3 million against $14.4 million reported last year.

Novavax, Inc. Proposes Amendments to Certificate of Incorporation and By-Laws

Novavax, Inc. proposed second amended and restated certificate of incorporation which increases the total number of authorized shares of the company's common stock, $0.01 par value from 300,000,000 shares to 600,000,000 shares and an amendment to the company's amended and restated by-laws to adopt a forum selection clause, to be considered for approval at the AGM to be held on June 18, 2015.

Novavax, Inc. to Report Q1, 2015 Results on May 07, 2015

Novavax, Inc. announced that they will report Q1, 2015 results at 4:30 PM, US Eastern Standard Time on May 07, 2015

Novavax, Inc., Q1 2015 Earnings Call, May 07, 2015

Novavax, Inc., Q1 2015 Earnings Call, May 07, 2015

Novavax, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-15-2015 08:00 AM

Novavax, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-15-2015 08:00 AM. Venue: Westin Grand Central Hotel, New York, New York, United States. Speakers: Stanley C. Erck, Chief Executive Officer, President, Director and Member of Finance Committee.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVAX:US $8.89 USD -0.045

NVAX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aduro Biotech Inc $31.39 USD -1.51
Advaxis Inc $27.18 USD -1.59
Celldex Therapeutics Inc $27.65 USD -0.85
Dynavax Technologies Corp $21.89 USD -0.65
ZIOPHARM Oncology Inc $9.69 USD +0.255
View Industry Companies
 

Industry Analysis

NVAX

Industry Average

Valuation NVAX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 65.2x
Price/Book 6.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 62.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVAVAX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.